Comparing the Efficacy and Safety of Intra-peritoneal Infusion of Catumaxomab and Treatment of Investigator Choice in Patients With Advanced Gastric Carcinoma With Peritoneal Metastasis
Clinical trial NCT04222114 · UNKNOWN
Trial details
- NCT number
- NCT04222114
- Sponsor
- LintonPharm Co.,Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-06
- Primary completion
- 2023-03-31
- Enrollment
- 282
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.